Related Experiment Video
Updated: Aug 8, 2026
High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
A chemiluminescence assay to detect antibodies to brain surface antigens in human sera
M Brügger1, E Dayrell-Hart, C Meier
1Institute of Animal Neurology, University of Berne, Switzerland.
Insights
A new chemiluminescence assay detects anti-brain antibodies in neurological diseases. This sensitive method identifies autoantibodies crucial for diagnosing conditions like autoimmune encephalitis.
Area of Science:
- Neuroimmunology
- Clinical Chemistry
Background:
- Autoantibodies against brain tissue are implicated in various neurological diseases.
- Detecting these autoantibodies is crucial for diagnosis and understanding disease mechanisms.
Purpose of the Study:
- To develop and validate a sensitive chemiluminescence assay for detecting anti-brain antibodies.
- To assess the prevalence of anti-brain antibodies in patients with neurological disorders.
Main Methods:
- A chemiluminescence assay was established utilizing the interaction between antibodies on brain cells and macrophages.
- Reactive oxygen radical production, triggered by this interaction, was measured.
- The assay was applied to serum samples from patients with neurological diseases; specificity was confirmed using IgG and F(ab')2 fragments.
Main Results:
- The chemiluminescence assay successfully detected anti-brain antibody activity in a significant proportion of patients with neurological diseases.
- Experiments confirmed the high specificity of the observed reactions, indicating accurate antibody detection.
Conclusions:
- The developed chemiluminescence assay is a sensitive and effective tool for detecting autoantibodies associated with neurological diseases.
- This technique holds promise for improved diagnosis and management of autoimmune neurological conditions.
Abstract:
A chemiluminescence assay was developed based on the interaction between antibodies binding to the surface of living brain cells in culture and macrophages. Such interaction leads to production of reactive oxygen radicals which can be measured by a chemiluminescence assay. This assay was used to detect anti brain antibodies in serum samples from humans with various neurological diseases. Such antibody activity was found in a high proportion of these patients. Subsequent experiments with purified IgG fractions and corresponding F(ab')2 fragments showed that the observed reactions were highly specific. It was concluded that the chemiluminescence assay is a sensitive and useful technique to detect autoantibodies in neurological diseases.
